BioSystems International - Product Pipeline Analysis

Summary

Biosystems International (BSI) is a biotechnology and pharmaceutical company, based in France. The company creates cutting edge blood-based diagnostics for early cancer detection and innovative antibody microarrays for blood-based biomarker research. It operates through product segments such as PlasmaScan and Quantiplasma Antibody Libraries. PlasmaScan 80 / PlasmaScan380 antibody arrays contain 80 and 380 (respectively) different mABs each reacting with different epitopes of the human plasma proteome. QuantiPlasma antibody library, allow precise proteome profiling without sample labeling. BSI provides service such as sample preparation and mAB production and characterization. The company is partnered with Amundi Asset Management, Gedeon Richter, Northeastern University, Randox Laboratories, Ltd and NKTH among others. BSI is headquartered in Evry Cedex, France.

This report is a source for data, analysis and actionable intelligence on the BioSystems International portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
BioSystems International - Major Products and Services 5
BioSystems International Pipeline Products by Development Stage 6
BioSystems International Pipeline Products by Therapy Area 8
Diagnostic Test - Alzheimer's Disease 10
Diagnostic Test - Alzheimer's Disease Product Status 10
Diagnostic Test - Alzheimer's Disease Product Description 10
Diagnostic Test - Breast Cancer 11
Diagnostic Test - Breast Cancer Product Status 11
Diagnostic Test - Breast Cancer Product Description 11
Diagnostic Test - Colon Cancer 12
Diagnostic Test - Colon Cancer Product Status 12
Diagnostic Test - Colon Cancer Product Description 12
Diagnostic Test - Lung Cancer 13
Diagnostic Test - Lung Cancer Product Status 13
Diagnostic Test - Lung Cancer Product Description 13
BioSystems International - Key Competitors 14
BioSystems International - Key Employees 15
BioSystems International - Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables

List of Tables
BioSystems International, Key Facts 1
BioSystems International Key Pipeline Products by Therapy Area 1
BioSystems International Key Pipeline Products by Development Stage 1
BioSystems International, Key Facts 4
BioSystems International, Major Products and Services 5
BioSystems International Number of Pipeline Products by Development Stage 6
BioSystems International Pipeline Products by Development Stage 7
BioSystems International Number of Pipeline Products by Therapy Area 8
BioSystems International Pipeline Products by Therapy Area 9
Diagnostic Test - Alzheimer's Disease - Product Status 10
Diagnostic Test - Alzheimer's Disease - Product Description 10
Diagnostic Test - Breast Cancer - Product Status 11
Diagnostic Test - Breast Cancer - Product Description 11
Diagnostic Test - Colon Cancer - Product Status 12
Diagnostic Test - Colon Cancer - Product Description 12
Diagnostic Test - Lung Cancer - Product Status 13
Diagnostic Test - Lung Cancer - Product Description 13
BioSystems International, Key Employees 15

List of Figures

List of Figures
BioSystems International Pipeline Products by Development Stage 6
BioSystems International Pipeline Products by Therapy Area 8